Navigation Links
STEER & Merck in Partnership for Collaborative Research on Processing Special Effect Pigments
Date:2/21/2017

BANGALORE, February 21, 2017 /PRNewswire/ --

Scientists From Two Companies to Accelerate Development of Appropriate Technology for Adoption by Plastic Industry 

STEER, creator of advanced materials platform technologies that effectively transform and functionalise materials in the fields of plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced a research collaboration with Merck, a leading science & technology company, on creating co-rotating twin screw extruder technology to effectively process special effect pigments.

     (Logo: http://mma.prnewswire.com/media/470101/STEER_Logo.jpg)

The research collaboration will focus on accelerating the development of an appropriate technology for the Plastic industry. STEER labs in India will carry out the research work involving its process know-how, technology platform and knowledge of materials transformation while Merck will contribute its understanding of pigments and core research work in plastics. STEER and Merck will jointly validate the research before taking to market the technology platform.

Commenting on the collaboration, Dr. Babu Padmanabhan, Managing Director and Chief Knowledge Officer, STEER, said, "This is a major milestone for STEER, as the collaboration is an acknowledgement of our capabilities and technology by a global leader. Our 21st century, co-rotating twin screw processor with fractional lobed elements allows for work on materials using precise application of forces - kneading, stirring or shearing material at specific zones of the processor - resulting in a quantum jump in process capability. With its ability to work with sensitive materials, our technology ushers in a new age of advanced materials through Intelligent Compounding. Our rich legacy of research and patented technologies complement this unique venture."

Gordon Price, Technical Service Manager, Pigments in Plastics, Merck, said, "STEER is pioneering materials transformation research in Plastics, and holds several patents. We believe in STEER's technology platform and research capabilities, which enjoy a proven track record. Through this research collaboration, we intend to master the co-rotating twin screw extruder technology to process special effect pigments and bring to market the most advanced platforms."

Processing special effects pigments is a challenge for the Plastic industry, as the pigment platelet structure gets damaged in the processing stage. Any alteration or change in the size of the structure hinders effective coloration and alters appearance of pigments in plastics. An appropriate process window is the way forward and STEER's technology platform is customised for producing effect pigment compounds and masterbatch.

For more, visit http://www.steerworld.com or write to aravind.gowda@steerworld.com


'/>"/>
SOURCE STEER Engineering Private Limited
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Vermillions CPRIT-Sponsored Pelvic Mass Registry Steering Committee Chartered
2. Bay Area BioEconomy Initiative Appoints Onyx Pharmaceuticals President Pablo Cagnoni to its Steering Committee
3. Hemostemix Meets with Newly Formed Clinical Trial Steering Committee
4. Steering stem cells with magnets
5. Global Bioplastics & Biopolymers Market Report 2017: Analysis, Trends & Industry Forecasts 2013-2025 - $8.9 Billion Growth Opportunities/Investment Opportunities - Research and Markets
6. BMT Tandem Meetings on Blood & Marrow Transplantation to be Held in Orlando
7. Upcoming MichBio BioMixer on 2/23/17, Hosted by MichBio & Avomeen
8. Slone Partners Places President & Chief Commercial Officer at GenePeeks
9. IDRI & NanoPass Sign Agreement to Develop an Intradermal rvRNA-Based Zika Virus Vaccine
10. Arcturus Therapeutics to Present at the 19th Annual BIO CEO & Investor Conference
11. Angionetics To Present At The Biotechnology Industry Organization CEO & Investor Conference At The Waldorf Astoria New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):